In a nonrandomized trial comparing robotic gastrectomy with fluorescence guidance and a two-port system (IRG) to conventional laparoscopic gastrectomy (CLG) for early gastric cancer, researchers found that IRG yielded more retrieved lymph nodes (42.1 vs. 35.1). The study suggests that the integrated robotic approach enhances lymphadenectomy and offers better perioperative outcomes, including shorter hospital stays […]

In clinical staging for early-stage esophageal cancer, 41.2% of patients experienced upstaging upon final pathology. Tumor size, histology, and delayed esophagectomy (>30 days) were linked to upstaging risk. The rate of achieving optimal oncologic outcomes dropped from 43.8% (reliable clinical staging) to 22.5% (considering upstaging). The study underscores the impact of inaccuracies in clinical staging […]

In the realm of gastric cancer surgery, a study flexes the stats on surgical approaches. Analyzing 21,015 patients, the research spotlights robotic gastrectomy (RG) as the champ, significantly elevating the likelihood of achieving Textbook Oncologic Outcome (TOO). Minimally invasive gastrectomy (MIG) emerges as a key player, linked to better lymph node evaluation, shorter hospital stays, […]

Researchers explored the global landscape of robot-assisted minimally invasive gastrectomy (RAMIG) for gastric cancer in a 2020-2023 registry spanning 25 centers. In 759 cases, RAMIG showcased varying techniques and excellent outcomes. Anastomotic leakage rates after total and distal gastrectomy reflected high surgical quality. The study sets a RAMIG quality standard, offering an international reference for […]

Researchers belted out a 3-year follow-up tune on the NEOCRTEC-1601 stage, where docetaxel, cisplatin, and fluorouracil (TPF) took the spotlight. For those with borderline-resectable esophageal squamous cell carcinoma (BR-ESCC), the act featured 54.4% survival rates at the 3-year mark. Surgery danced into the spotlight for 57.4% of patients, confirming TPF’s encore as a promising rhythm […]

Researchers staged a retrospective showdown between total omentectomy (TO) and partial omentectomy (PO) in the radical gastrectomy arena for advanced gastric cancer (AGC) with serosal invasion. The verdict? No VIP pass for TO in preventing peritoneal recurrence. PO stole the spotlight with comparable recurrence-free survival and a better 5-year overall survival. Turns out, for T4a […]

Researchers lit up esophageal cancer surgery with near-infrared indocyanine green, exposing the elusive thoracic duct (TD) in 94% of cases. Injecting ICG into inguinal nodes during minimal access esophagectomy, the team showcased real-time TD imaging. The glow guided ligation in 16 cases, minimizing chyle leaks and sidestepping adverse reactions. This illuminating approach, sustaining fluorescence throughout, […]

Researchers delved into the LOGICA trial, scrutinizing complications after gastric cancer surgery. Comparing Comprehensive Complication Index (CCI) and Clavien-Dindo Classification (CDC), they discovered no significant difference in complication burden between laparoscopic and open D2-gastrectomy. The verdict? While both indices correlated for hospitalization, ICU-stay, and reoperations, the CCI brought no extra flair, advising against its use […]